Have We Entered the Era of Imaging Before Salvage Treatment for Recurrent Prostate Cancer?
editorial · Level V
Where this comes from
- Record sourced from PubMed, PMID 31031049.
- Also identified by DOI 10.1016/j.eururo.2019.04.016.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The role of imaging before salvage treatment of recurrent prostate cancer is controversial. Knowledge of site-specific recurrence obtained from novel imaging techniques such as prostate-specific membrane antigen-based positron emission tomography/computed tomography might provide information on the benefit of imaging before salvage therapies.
Medical subject headings
- Neoplasm Recurrence, Local
- Positron Emission Tomography Computed Tomography
- Prostatic Neoplasms
- Salvage Therapy